REFERENCES
- Alkylphosphocholines: an update. 1998. Drugs of Today 34 (Suppl. F).
- Arndt, D., Fichtner, I., and Nissen, E. 1987. Liposomes as carrier of methyl- GAG, increased antitumor activity and reduced hypoglycemi a in mice. Oncology 44:257 – 262.
- Arndt, D., Zeisig, R., Eue, I., Sternberg, B., and Fichtner, I. 1997. Antineoplas- tic activity of sterically stabilized alkylphosphocholin e liposomes in human breast carcinomas. Breast Cancer Res. Treat. 43:237– 246.
- Arndt, D., Zeisig, R., and Fichtner, I. 1998. Alkylphospholipi d liposomes: prepa- ration, properties and use in cancer research. Drugs of Today 34 (Suppl. F):83–96.
- Arndt, D., Zeisig, R., Fichtner, I., Teppke, A. D., Fahr, A. 1999. Pharma- cokinetics of sterically stabilized hexadecylphosphocholin e liposomes ver- sus conventiona l liposomes and free hexadecylphosphocholin e in tumor-free and human breast carcinoma bearing mice. Breast Cancer Res. Treat. 58:71 – 80.
- Fichtner, I., Arndt, D., Reszka, R., and Gens, J. 1991. Pharmacokineti k behavior of [57Co]bleomyci n liposomes in mice: comparison with the unencapsulate d substance. Anticancer Drugs 2:555– 563.
- Gabizon, A., Price, D., and Huberty, J. 1990. Effect of liposome composition and other factors on the targeting of liposomes to experimenta l tumors: biodistri- bution and imaging studies. Cancer Res. 50:6371– 6382.
- Hirnle, P. 1997. Liposomes for drug targeting in the lymphatic system. Hybridoma 16:127– 132.
- Janoff, A., ed. 1998. Liposomes, Rational Design. New York: Marcel Dekker. Lasic, D., and Papahadjopoulos, D., eds. 1998. Medical Applications of Liposomes. New York: Elsevier. Lazo, J., and Sebti, S. 1997. Bleomycin. In: Pinedo, H. M., Longo, D. I., Chabner, B. A., eds. Cancer Chemotherap y and Biological Modifiers Annual 17. Elsevier Science B.V., 40–45. Maekawa, S., Sugimachi, K., and Kitamura, M. 1987. Selective treatment of metastatic lymph nodes with combination of local hyperthermia and temperature-sensitive liposomes containing bleomycin. Cancer Treat. Rep. 71:1053 – 1059.
- Naresh, R. A., Udupa, N., and Devi, P. U. 1996. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice. Indian J. Exper. Biol. 34:764 – 772.
- Nuhn, P., Schenk, P., Richter, H., Arndt, D., Jandrig, J., and Winsel, K. 1985. Untersuchunge n an Liposomen aus hydriertem Eilecithin. Pharmazie 40:705 – 709.
- Poujol, S., Tilleul, P., Astre, C., Martel, P., Fabbro, M., and Pinguet, F. 1999. Effect of mitoxantrone liposomes on multidrug-resistan t breast cancer cells. Anticancer Res. 19:3327 – 3331.
- Puisieux, F., Couvreur, P., Delattre, J., and Devissaguet, J. P., eds. 1995. Lipo- somes, New Systems and New Trends in Their Applications. Paris: Editions de Sante´.
- Roy, R., and Kim, S. 1991. Multivesicular liposomes containing bleomyci n for subcutaneou s administration. Cancer Chemother. Pharmacol. 28:105– 108.
- Segal,. W., Gregoriadis, G., Lavender, J. P., Tarin, D., and Peters, T. J. 1976. Tissue and hepatic subcellular distribution of liposomes containing bleomycin after intravenou s administration to patients with neoplasms. Clin. Sci. Mol. Med. 51:421– 425.
- Sikic, B., Young, D., and Minnaugh, E. 1978. Quantification of bleomycin pul- monary toxicity in mice by changes in lung hydroxyprolin e content and mor- phometric histopathology. Cancer Res. 38:787– 792.
- Sikic, B., Siddik, Z., and Gram, T. 1980. Relative pulmonary toxicity and anti- tumor effects of two new bleomycin analogs, pepleomyci n and tallysomycin A1. Cancer Treat. Rep. 64:659– 667.
- Sludden, J., Uchegbu, I. F., and Scha¨tzlein, A. G. 2000. The encapsulatio n of bleomycin within chitosan based polymeric vesicles does not alter its biodis-tribution. J. Pharm. Pharmacol. 52:377– 382.
- Sur, R., Hasra, B., and Roy, D. K. 1984. Enhancemen t of the activity of bleomycin on Ehrlich ascites carcinoma cells by liposomal encapsulation. Indian J. Exper. Biol. 22:115– 119.
- Tanneberger, S., and Bacigalupo, G. 1967. Zu¨chtung eines permanente n Zell-stammes aus einem hormonab ha¨ngigen Mammakarzinom der Ratte (Huggins tumor). Naturwiss. 54:566 – 567.
- Zeisig, R., Eue, I., Kosch, M., Fichtner, I., and Arndt, D. 1996. Preparation and properties of sterically stabilized hexadecylphosphocholin e (miltefosine)- liposomes and influence of this modification on macrophag e activation. Biochim. Biophys. Acta 1283:177– 184.
- Zeisig, R., Arndt, D., Stahn, R., and Fichtner, I. 1998. Physical properties and pharmacologica l activity in vitro and in vivo of optimised liposomes pre- pared from a new cancerostatic alkylphospholipid. Biochim. Biophys. Acta 1414:238 – 248.